Surgery Partners (Nasdaq: SGRY) remains committed to organizational growth and M&A as it enters the final quarter of the year. That’s based on remarks by CEO Eric Evans during the company’s Q3 2025 earnings call. Broadly, Surgery Partners is focused on its three growth pillars: organic growth, margin improvement and capital deployment for M&A to showcase ongoing execution and alignment with its long-term growth strategy. Surgery Partners has invested around $71 million in capital for acquisitions, adding multiple facilities to its portfolio. It also sold stakes in three ASCs for about $50 million.
Read the full article: Surgery Partners Reaffirms Long-Term Strategy Despite Volume Dips, Changing Payer Mix //
Source: https://ascnews.com/2025/11/surgery-partners-reaffirms-long-term-strategy-despite-volume-dips-changing-payer-mix/